Revolutionizing Colorectal Surgery with SureForm™ Staplers

The Role of Robotic SureForm™ Staplers in Intracorporeal Anastomosis for Colectomy and Rectal Cancer Surgery: Evidence, Patient Benefits, and Cost Implications

By Dr. Jagdishwar Goud Gajagowni

Apollo Hospitals, Hyderabad, Telangana, India

The landscape of colorectal cancer surgery has transformed dramatically with the advent of robotic platforms, especially in challenging pelvic dissections. One of the most impactful innovations in this space is the SureForm™ robotic stapler, integrated seamlessly with the da Vinci Xi system. As more surgeons transition to a fully robotic approach, it’s vital to examine how SureForm is reshaping intracorporeal anastomosis (ICA) in colectomy and rectal cancer surgeries—with real-world benefits in outcomes and cost.

Understanding the SureForm™ Advantage

CLICK HERE FOR YOUTUBE VIDEO OF TECHNIQUE

SureForm™ is a next-generation stapling system offering:

• SmartFire™ Technology: Continuously monitors tissue compression and optimizes firing for consistent staple formation.
• 120° Wristed Articulation: Critical for stapling in narrow or deep pelvic spaces.
• Console-Controlled Integration: Gives the surgeon complete control, minimizing the need for an assistant during key steps like transection or anastomosis.

Why Intracorporeal Anastomosis Matters

Robotic platforms now make ICA not just possible, but preferable in many cases. Key advantages:

• Reduced Bowel Manipulation
• Smaller Extraction Site – minimizing the risk of incisional hernias
• Improved Alignment – especially in low pelvic or obese patients
• Lower Leak Rates – in selected patient cohorts

Evidence That Supports Robotic Stapling

1. ROLARR Trial (2017): While not specific to SureForm, this landmark trial confirmed robotic rectal resection’s non-inferiority, emphasizing the technical challenges of stapling deep in the pelvis—challenges that SureForm helps address.
2. Briganti et al., EJSO 2022: Showed that ICA using SureForm in sigmoid and low anterior resections had lower leak rates (4.2%) versus ECA (7.1%), with earlier bowel function recovery and less pain.
3. Cleveland Clinic (2023): In 350 matched robotic rectal resections, SureForm ICA led to reduced need for diverting ileostomies without increasing leak risk.
4. Multicenter Retrospective Data (2020–2023): Consistently demonstrates fewer misfires, better staple formation, and improved orientation in ICA using SureForm.

Tangible Patient Benefits

• Shorter Hospital Stay – reduction of 0.5–1.5 days in several series
• Faster Recovery – earlier bowel movement, less postoperative discomfort
• Smaller Incisions – better cosmetic outcomes and reduced hernia risk
• Improved Precision – especially in male patients with narrow pelvises

Cost Considerations: Breaking the Myth

There’s a common misconception that robotic staplers are more expensive. In reality, SureForm staplers are often more cost-effective than laparoscopic staplers when used appropriately.

Here’s why:

1. Fewer Stapler Firings: SmartFire™ technology often achieves a clean transection with fewer reloads.
2. Less Need for Relinear Stapling: Reduced wastage and re-firing.
3. Efficiency: No instrument hand-offs; improved flow and reduced OT time.
4. Fully Robotic Approach: Minimizes use of costly laparoscopic tools.
5. Real-World Data: High-volume centers report 10–20% lower total procedural cost using SureForm compared to hybrid or laparoscopic staplers—especially in sigmoid and low anterior resections.

Conclusion

SureForm™ robotic staplers are more than just a tool—they represent a leap forward in precision, safety, and efficiency for colorectal surgery. Their utility in intracorporeal anastomosis makes them especially valuable in anatomically difficult cases, with growing evidence of improved outcomes and cost savings.

As we move toward greater standardization in robotic surgery, SureForm is enabling surgeons to achieve reproducible, safe, and patient-centered results—while also being economically sensible.

Future Directions

The surgical community awaits randomized, SureForm-specific trials in robotic colorectal surgery. Meanwhile, the focus must remain on training, protocol development, and mentorship—ensuring safe adoption and optimization of this powerful technology across centers of all sizes.

If you’re a colorectal surgeon or a hospital administrator exploring ways to optimize robotic outcomes, the SureForm™ stapler is worth serious consideration—not just for its articulation, but also for its impact on patients and the bottom line.